These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 25749735

  • 1. Azithromycin for acute lower respiratory tract infections.
    Laopaiboon M, Panpanich R, Swa Mya K.
    Cochrane Database Syst Rev; 2015 Mar 08; 2015(3):CD001954. PubMed ID: 25749735
    [Abstract] [Full Text] [Related]

  • 2. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD001954. PubMed ID: 18253999
    [Abstract] [Full Text] [Related]

  • 3. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD001954. PubMed ID: 15497172
    [Abstract] [Full Text] [Related]

  • 4. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S, Gavranich JB, Gillies MB, Chang AB.
    Cochrane Database Syst Rev; 2012 Sep 12; (9):CD004875. PubMed ID: 22972079
    [Abstract] [Full Text] [Related]

  • 5. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Gardiner SJ, Gavranich JB, Chang AB.
    Cochrane Database Syst Rev; 2015 Jan 08; 1(1):CD004875. PubMed ID: 25566754
    [Abstract] [Full Text] [Related]

  • 6. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E, House H, Lockhart K, Purchuri SN, Pushparajah J, Cripps AW, van Driel ML.
    Cochrane Database Syst Rev; 2014 Sep 09; (9):CD010010. PubMed ID: 25201571
    [Abstract] [Full Text] [Related]

  • 7. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E, Lockhart K, Purchuri SN, Pushparajah J, Cripps AW, van Driel ML.
    Cochrane Database Syst Rev; 2017 Jun 19; 6(6):CD010010. PubMed ID: 28626902
    [Abstract] [Full Text] [Related]

  • 8. Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age.
    Rojas-Reyes MX, Granados Rugeles C, Charry-Anzola LP.
    Cochrane Database Syst Rev; 2014 Dec 10; 2014(12):CD005975. PubMed ID: 25493690
    [Abstract] [Full Text] [Related]

  • 9. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM, Möllers MJ, van Schie MH, Greefhorst AP, Schlösser NJ, Sinninghe Damsté EJ, van de Moosdijk CN, Dalinghaus WH, Eland ME, Mol SJ, Rozenberg-Arska M.
    Int J Antimicrob Agents; 1997 Jan 10; 9(3):141-6. PubMed ID: 9552709
    [Abstract] [Full Text] [Related]

  • 10. Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age.
    Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ.
    Cochrane Database Syst Rev; 2014 Feb 18; (2):CD007880. PubMed ID: 24535959
    [Abstract] [Full Text] [Related]

  • 11. Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age.
    Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ.
    Cochrane Database Syst Rev; 2016 Feb 29; 2(2):CD007880. PubMed ID: 26923064
    [Abstract] [Full Text] [Related]

  • 12. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R.
    J Int Med Res; 1991 Feb 29; 19(5):373-83. PubMed ID: 1660824
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections.
    Contopoulos-Ioannidis DG, Ioannidis JP, Chew P, Lau J.
    J Antimicrob Chemother; 2001 Nov 29; 48(5):691-703. PubMed ID: 11679558
    [Abstract] [Full Text] [Related]

  • 14. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
    Mulholland S, Gavranich JB, Chang AB.
    Cochrane Database Syst Rev; 2010 Jul 07; (7):CD004875. PubMed ID: 20614439
    [Abstract] [Full Text] [Related]

  • 15. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB, Grimwood K, Wilson AC, van Asperen PP, Byrnes CA, O'Grady KA, Sloots TP, Robertson CF, Torzillo PJ, McCallum GB, Masters IB, Buntain HM, Mackay IM, Ungerer J, Tuppin J, Morris PS.
    Trials; 2013 Feb 20; 14():53. PubMed ID: 23421781
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC, Poole P.
    Cochrane Database Syst Rev; 2013 Nov 28; (11):CD009764. PubMed ID: 24288145
    [Abstract] [Full Text] [Related]

  • 17. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P, Mangunnegoro H, Yunus F, Gunawan J.
    Respirology; 1998 Jun 28; 3(2):113-7. PubMed ID: 9692520
    [Abstract] [Full Text] [Related]

  • 18. Antibiotics for acute bronchitis.
    Smith SM, Fahey T, Smucny J, Becker LA.
    Cochrane Database Syst Rev; 2014 Mar 01; (3):CD000245. PubMed ID: 24585130
    [Abstract] [Full Text] [Related]

  • 19. Pelargonium sidoides extract for treating acute respiratory tract infections.
    Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV.
    Cochrane Database Syst Rev; 2013 Oct 22; (10):CD006323. PubMed ID: 24146345
    [Abstract] [Full Text] [Related]

  • 20. Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
    File TM, Jacobs MR, Poole MD, Wynne B, 546, 547, 548, 549, 550, 551, 556, 557 and 592 Clinical Study Groups.
    Int J Antimicrob Agents; 2002 Oct 22; 20(4):235-47. PubMed ID: 12385678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.